OmniAb, Inc. (OABI)
OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
$1.96-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+2.4%
The outlook
OmniAb, Inc. currently reads as neutral based on mixed vs its moving averages, 44% of the way from its 52-week low to high, avg target +275% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range44% of the way from its 52-week low to high
Price targetAvg target +275% vs current price
Analyst price target
~12-month · 6 analysts$7.33average target+275.1% vs now
Now $1.96
Low $3.00High $11.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$283.4M
52-wk high
$2.79
52-wk low
$1.30
50-day avg
$2.32
200-day avg
$1.88
Trailing P/E
—